由《Bentham Science》出版社出版。ISSN: 1568 - 0096。《當(dāng)前癌癥藥物靶標(biāo)》旨在涵蓋藥物化學(xué)、藥理學(xué)、分子生物學(xué)、基因組學(xué)和當(dāng)代癌癥分子藥物靶標(biāo)生物化學(xué)(如疾病特異性蛋白、受體、酶、基因)的所有最新和杰出的發(fā)展。該雜志的每一期都包含了一系列由該領(lǐng)域的領(lǐng)導(dǎo)者撰寫(xiě)的及時(shí)深入的評(píng)論，涵蓋了與癌癥有關(guān)的藥物靶點(diǎn)的一系列當(dāng)前主題。隨著用于抗癌藥物發(fā)現(xiàn)的新型人類(lèi)藥物靶點(diǎn)的發(fā)現(xiàn)、鑒定、表征和驗(yàn)證的不斷增長(zhǎng);這本雜志將是所有參與藥物發(fā)現(xiàn)和開(kāi)發(fā)的藥物學(xué)家的必讀書(shū)。

Published by Bentham Science Publishers. ISSN: 1568-0096.Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer. As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.